Evaluating Safety and Efficacy of DAPT Duration by Gender Post-PCI



Treatment with two antiplatelet medications, including aspirin and a purinergic receptor inhibitor targeting P2Y12, is advised following percutaneous coronary intervention to lower the likelihood of blood clot-related complications.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our